Health and Healthcare

IPO FILING: Salient Surgical Technologies, Inc. (SLNT, MDT)

Salient Surgical Technologies, Inc. has filed to come public via an initial public offering and has applied to trade on the NASDAQ under the ticker "SLNT."  The company lists that it will sell up to $86.25 million in securities for filing purposes.  Co-lead managers are listed as Bear Stearns and Piper Jaffray, and Wachovia Securities in listed as a co-manager.

This company offers what it refers to as clinical applications of Transcollation(tm) technology for the sealing of blood vessels and other collagen-based structures.  These are for medical procedures such as liver resection, spine surgery, total hip athroplasty, and total knee athroplasty. Transcollation technology has been used in over 165,000 surgical procedures to date. Its principal Transcollation product is called the Aquamantys System and it was launched commercially in March 2006, and it is comprised of single-use handheld devices and a radio frequency energy generator system.

Unlike many medical technology companies that have filed to come public, this one is now operational with at least some revenues. As of December 31, 2007, it claimed to have some 437 active customer accounts in the United States, a 44% increase over the comparable period in 2006.  It also notes that its target market remains substantially underpenetrated and it believes the current accounts represent only an approximate 10% of hospitals in the United States which perform its targeted procedures.  Revenues for the year ended December 31, 2007 were $29.5 million, a 75% increase from 2006.

While most of the Dover, NH-based company’s backers are VC’s, it does note that entities affiliated with Medtronic, Inc. (NYSE: MDT) are listed as being a 8.8% owner of the company.

Jon C. Ogg
March 13, 2008

It’s Your Money, Your Future—Own It (sponsor)

Retirement can be daunting, but it doesn’t need to be.

Imagine having an expert in your corner to help you with your financial goals. Someone to help you determine if you’re ahead, behind, or right on track. With SmartAsset, that’s not just a dream—it’s reality. This free tool connects you with pre-screened financial advisors who work in your best interests. It’s quick, it’s easy, so take the leap today and start planning smarter!

Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.